Allogenic CD123-CAR-NK Cells in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia

NCT05574608 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia Refractory
Acute Myeloid Leukemia Recurrent

Interventions

BIOLOGICAL: CD123-CAR-NK cells

Sponsor

Affiliated Hospital to Academy of Military Medical Sciences

Collaborators

[object Object]